Akorn Files For Ch. 7 Liquidation With Over $100M Debt
Remnants of recently bankrupt specialty pharmaceutical venture Akorn Pharmaceuticals and two affiliates have crossed over from Chapter 11 to Chapter 7 liquidation in Delaware, with a worker complaint in tow alleging...To view the full article, register now.
Already a subscriber? Click here to view full article